Tradestie Institutional Equity Comparison Engine
CELUW vs CELU โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CELU Overall Edge
CELU Captures Institutional Edge (3โ0 Pillars ยท 7โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Celularity Inc. Class A Common Stock (CELU) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CELUW trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CELU at N/M Forward P/E and -254.0% operating margin (-5.3% YoY). In options structure, CELUW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CELU sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CELUW N/M vs CELU N/M Fwd P/E
Growth & Margin Winner
CELU
Op Margin N/A vs -254.0% ยท YoY N/A vs -5.3%
Momentum & Technical Winner
CELU
1Y -95.2% vs -72.6% ยท 52W Pos 2% vs 2%
Options & Structure Winner
CELU
UNCLASSIFIED (N/A IV) vs BREAKDOWN (50th %ile IV)
CELUW
US Equity
CELUW
Institutional Equity
$0.00
+533.33% 1D
Market Cap
N/A
1M Return
-54.76%
1Y Return
-95.25%
Forward P/E
N/M
Unified AI Score
41.3 / 100
SELL
Tech 25.0
Fund 42.0
Flow 50.0
Mom 50.0
CELU
NASDAQ
Celularity Inc. Class A Common Stock
Pharmaceutical Preparations
$0.46
-1.05% 1D
Market Cap
$15.2M
1M Return
-55.9%
1Y Return
-72.6%
Forward P/E
N/M
Unified AI Score
42.9 / 100
HOLD
Tech 25.0
Fund 48.0
Flow 67.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CELUW -95.25%
CELU -72.6%
Spread: +38.97 pp (CELU Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CELUW TTM Op. Margin: N/A
CELU TTM Op. Margin: -254.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CELUW vs CELU. Trailing 12-month operating profitability (CELUW N/A vs CELU -254.0%) and valuation multiples (CELUW N/M vs CELU N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CELUW | CELU | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $15.2M | Larger Scale | CELU |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | -5.3% | Higher Growth | CELU |
| Operating Margin (TTM) Profitability | N/A | -254.0% | Higher Margin | CELU |
| Net Profit Margin Profitability | N/A | -245.7% | Higher Margin | CELU |
| Return on Equity (ROE) Capital Efficiency | N/A | -6367.2% | Higher ROE | CELU |
| 52-Week Range Position Momentum | 2% ($0โ$0) | 2% ($0โ$3) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 1.52ฮฒ ยท 2163% Vol | 2.01ฮฒ ยท 135% Vol | Lower Realized Risk | CELU |
| Unified Institutional Score Composite Signal | 41.3 / 100 (SELL) | 42.9 / 100 (HOLD) | Higher Composite | CELU |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CELUW vs CELU Buy Guide
CELUW
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CELU
BREAKDOWN
60d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
50th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CELUW nor CELU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.